ITMCTR2000003182尚未招募4 期
Post - marketing reevaluation of shengu granule in the treatment of senile osteoporosis.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 性别
- All
入选标准
- •Those who meet the diagnostic criteria of senile osteoporosis.
排除标准
- •(1) patients with chronic low back diseases (such as: osteomyelitis, bone tumor, rheumatoid arthritis, bone tuberculosis or vertebral body weight degree slippage, or patients with spinal cord caudate nerve damage, etc.);
- •(2) patients with hyperthyroidism, hyperparathyroidism, gastrectomy, diabetes Paget's disease and other related diseases that may cause secondary osteoporosis;
- •(3) allergic constitution or allergic to the known ingredients of the drug;
- •(4) patients with heart, lung, liver, kidney, hematopoietic system, immune system and other serious diseases.
研究者
相似试验
招募中
4 期
Post-marketing reevaluation of Zhuifeng Tougu capsule in treating Rheumatoid ArthritisRheumatoid ArthritisITMCTR2000002895Temporarily not sure
尚未招募
4 期
Post-marketing clinical re-evaluation of Guanxinning Tablet, a big brand Chinese patent medicine, in the treatment of angina pectoris after PCIanginaITMCTR2200005530Run Run Shaw Hospital, Zhejiang University School of Medicine
尚未招募
4 期
Reevaluation of kidney-bone granule after marketing in the treatment of osteoarthritis.OsteoarthritisITMCTR2000003178Temporarily not sure
进行中（未招募）
不适用
A post market clinical follow-up study with the short stem uncemented endoprosthesis (optimys) BMI > 40M16.1M16.7Other primary coxarthrosisOther secondary coxarthrosisDRKS00014719Mathys Orthopädie GmbH10
已完成
不适用
A post market clinical follow-up study with the short stem uncemented endoprosthesis (optimys )M16.1M16.7Other primary coxarthrosisOther secondary coxarthrosisDRKS00014711Mathys Orthopädie GmbH224